Angel Sánchez Rodríguez-rekin lankidetzan egindako argitalpenak (3)

2012

  1. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes

    European Journal of Clinical Investigation, Vol. 42, Núm. 5, pp. 548-556